Trilio-Medical
Transcatheter Implant for Tricuspid Valve Repair
Company Overview
Snapshot
Founded in November 2022 by Yuval Raz, Trilio-Medical operates with 1–10 employees. The company has raised $2.1M across one funding round from one investor, MEDX Xelerator. This seed funding underscores early investor confidence in its innovative medical device technology.
Business overview
Trilio-Medical is a medical device company focused on developing a novel transcatheter implant and delivery system for tricuspid valve repair. The company's core technology is designed to enhance valve coaptation, offering a sophisticated and efficient treatment solution. Trilio-Medical aims to significantly reduce the severity of tricuspid regurgitation, primarily serving the healthcare and medical devices sectors in markets such as Israel and the United States.
Log in to access full profile ›Company Intelligence Q&A
- When was Trilio-Medical founded?
- Trilio-Medical was founded in November 2022.
- Who is the founder of Trilio-Medical?
- Yuval Raz is the Founder & CEO of Trilio-Medical.
- What is Trilio-Medical's primary focus?
- Trilio-Medical develops a novel transcatheter implant and delivery system for tricuspid valve repair, designed to increase valve coaptation and reduce tricuspid regurgitation severity.
- In which sector does Trilio-Medical primarily operate?
- Trilio-Medical operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices.